Douglas Golenbock

Dr. Douglas Golenbock is Chief of the Division of Infectious Diseases and Immunology in the Department of Medicine. He holds a joint appointment in the Department of Microbiology and Physiological Systems. He was educated at the University of Michigan and, after college and medical school, received postgraduate training at George Washington University, the University of Wisconsin, the Rockefeller University and Merck Research Laboratories in Rahway. He is especially interested in the role of Toll-like receptors, and related innate immune receptors, in the basic inflammatory response to infectious pathogens such as malaria, and in degenerative neurological diseases such as Alzheimer’s Disease. Dr. Golenbock also has expertise in how these same innate immune pathways can be harnessed by chemicals known as adjuvants to improve the immune response to vaccines.